The Valley Desk

Clinical trial reportAmerican journal of hematologyPublished

Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study

12 of 38 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
American journal of hematology
Published
Subject terms
Humans; Lymphoma, Non-Hodgkin; Sulfonamides; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal; Immunoconjugates; Myeloid Cell Leukemia Sequence 1 Protein; Rituximab; Bridged Bicyclo Compounds, Heterocyclic
PubMed ID
36594167
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal